Recent updates on animal models for understanding the etiopathogenesis of polycystic ovarian syndrome

被引:49
|
作者
Corrie, Leander [1 ]
Gulati, Monica [1 ]
Singh, Sachin Kumar [1 ]
Kapoor, Bhupinder [1 ]
Khursheed, Rubiya [1 ]
Awasthi, Ankit [1 ]
Vishwas, Sukriti [1 ]
Chellappan, Dinesh Kumar [2 ]
Gupta, Gaurav [3 ]
Jha, Niraj Kumar [4 ]
Anand, Krishnan [5 ]
Dua, Kamal [6 ]
机构
[1] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara 144411, Punjab, India
[2] Int Med Univ, Sch Pharm, Dept Life Sci, Kuala Lumpur 57000, Malaysia
[3] Suresh Gyan Vihar Univ, Sch Pharm, Mahal Rd, Jaipur, Rajasthan, India
[4] Sharda Univ, Sch Engn & Technol SET, Dept Biotechnol, Greater Noida 201310, Uttar Pradesh, India
[5] Univ Free State, Fac Hlth Sci, Sch Pathol, Dept Chem Pathol,Natl Hlth Lab Serv, Bloemfontein, South Africa
[6] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, Australia
关键词
Polycystic ovarian syndrome; Luteinizing hormone; Dehydroepiandrosterone model; Dihydrotestosterone model; Letrozole; SEX STEROID-RECEPTORS; ESTRADIOL VALERATE; RAT MODEL; INSULIN-RESISTANCE; FOLLICULAR DEVELOPMENT; LUTEINIZING-HORMONE; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION; CYSTIC OVARIES;
D O I
10.1016/j.lfs.2021.119753
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Polycystic ovarian syndrome (PCOS) is the primary cause of female infertility affecting several women worldwide. Changes in hormonal functions such as hyperandrogenism are considered a significant factor in developing PCOS in women. In addition, many molecular pathways are involved in the pathogenesis of PCOS in women. To have better insights about PCOS, it is data from clinical studies carried on women suffering from PCOS should be collected. However, this approach has several implications, including ethical considerations, cost involved and availability of subject. Moreover, during the early drug development process, it is always advisable to use nonhuman models mimicking human physiology as they are less expensive, readily available, have a shorter gestation period and less risk involved. Many animal models have been reported that resemble the PCOS pathways in human subjects. However, the models developed on rats and mice are more preferred over other rodent/non-rodent models due to their closer resemblance with human PCOS development mechanism. The most extensively reported PCOS models for rats and mice include those induced by using testosterone, letrozole and estradiol valerate. As the pathophysiology of PCOS is complex, none of the explored models completely surrogates the PCOS related conditions occurring in women. Hence, there is a need to develop an animal model that can resemble the pathophysiology of PCOS in women. The review focuses on various animal models explored to understand the pathophysiology of PCOS. The article also highlights some environmental and food-related models that have been used to induce PCOS.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Polycystic ovarian syndrome and the metabolic syndrome
    Sartor, BM
    Dickey, RP
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 330 (06): : 336 - 342
  • [32] Can Polycystic Ovarian Syndrome be cured? Unfolding the Concept of Secondary Polycystic Ovarian Syndrome!
    Khadilkar, Suvarna Satish
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2019, 69 (04): : 297 - 302
  • [33] What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome
    Homburg, R
    HUMAN REPRODUCTION, 2002, 17 (10) : 2495 - 2499
  • [34] Can Polycystic Ovarian Syndrome be cured? Unfolding the Concept of Secondary Polycystic Ovarian Syndrome!
    Suvarna Satish Khadilkar
    The Journal of Obstetrics and Gynecology of India, 2019, 69 : 297 - 302
  • [35] Understanding the Pathogenesis of Angelman Syndrome through Animal Models
    Jana, Nihar Ranjan
    NEURAL PLASTICITY, 2012, 2012
  • [36] Effect of Acupuncture on Polycystic Ovary Syndrome in Animal Models: A Systematic Review
    Li, Yan
    Zhang, Lijia
    Gao, Jinjin
    Yan, Jun
    Feng, Xue
    He, Xiting
    Jin, Hong
    Li, Xinyu
    Cui, Zhengyi
    Zhao, Junfei
    Liu, Fengyi
    Liu, Xiaowai
    Liu, Yongfei
    Ren, Wan
    Liu, Songjiang
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [37] Epigenetic studies of ovarian cells: understanding the aetiology and management of Polycystic Ovary Syndrome
    Makrinou, E.
    Drong, A.
    Masrour, N.
    Christopoulos, G.
    Lerner, A.
    Caraderi, T.
    Hardy, K.
    Lindgren, C.
    Franks, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 754 - 754
  • [38] Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models
    Mizoguchi, Emiko
    Low, Daren
    Ezaki, Yui
    Okada, Toshiyuki
    INTESTINAL RESEARCH, 2020, 18 (02) : 151 - 167
  • [39] Therapy for polycystic ovarian syndrome
    Wei, AY
    Pritts, EA
    CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (06) : 678 - 682
  • [40] POLYCYSTIC OVARIAN SYNDROME AND HYPERINSULINAEMIA
    Adil, Fauzia
    Ansar, Humera
    Munir, Aftab A.
    JOURNAL OF THE LIAQUAT UNIVERSITY OF MEDICAL AND HEALTH SCIENCES, 2005, 4 (03): : 89 - 93